With over 21,000 successful urology and sexology surgeries under his belt, Dr Ashish Saini, a specialist in Urology, trained at AIIMS, New Delhi, is bringing relief to innumerable patients with his expertise in the latest tech methodologies and interventions
Dr Ashish Saini, Urologist Founder and Director Excel Advanced Urology Centre Greater Kailash 1, New Delhi
Look around, and you will find almost every other person consumed with some or other chronic disease. Being home to the second-highest number of diabetes patients, India also accounts for 60 per cent of the world’s heart disease burden. Hypertension, chronic kidney disease, and liver ailments-contribute notably to increasing complications and risks while treating other illnesses like Benign Prostatic Hyperplasia (BPH).
Besides restricting to limited treatment options to avail from, the presence of chronic diseases also heightens the risks associated with medications and surgical procedures like anaesthesia. It implies that men diagnosed with BPH and chronic diseases like diabetes, hypertension or heart problems cannot undergo the majority of surgical treatments for BPH condition because it may put the patient’s life at risk. Now, the question arises what alternatives are available for such patients? Is it safe for BPH patients with chronic ailments to be on medications for a long time? Do minimally invasive therapies prove beneficial to BPH patients with chronic disease? The answer to all these questions is minimally invasive therapies like Urolift, PUL etc. It is a minimally invasive BPH treatment that allows rapid relief and recovery for men living with Benign Prostatic Hyperplasia without causing sexual dysfunction. This system places small implants to hold open the obstructed pathway blocking the urine flow, eliminating primary problems associated with BPH.
Benign Prostatic Hyperplasia (BPH) It is a condition detected in ageing men, which refers to non-malignant growth or hyperplasia of prostate tissue. There are several definitions available that describe Benign Prostatic Hyperplasia (BPH), including bladder outlet obstruction (BOO), lower urinary tract symptoms (LUTS) and benign prostatic enlargement (BPE). While BPH describes histological changes, BOO and BPE describe the obstruction to flow and increased gland size, respectively.
Treatment options for BPH patients range from watchful waiting to medical and surgical interventions that might not conform with all BPH patients increasing risks and complications. Albeit, minimally invasive BPH treatments like Urolift and PUL evolved over the last few years and have significantly filled this gap and are providing safe and effective BPH treatments, even to patients with chronic diseases.
How minimally invasive BPH treatment is beneficial for chronic disease patients?
Patients with chronic ailments like heart disease, hypertension, diabetes, kidney problem or liver issues are prone to more risk while undergoing any surgical treatments. Therefore, minimally invasive BPH treatments are beneficial for such patients because:
It is hard to maintain blood pressure and blood glucose levels during operations.
Fluctuations in vitals can occur anytime during surgery, causing constant fear of threat to life.
Even injecting anaesthesia into heart patients can create complications while performing surgery to treat BPH.
If not surgery, medications remain the only option for men with BPH and chronic disease, which also proves troublesome in future.
Speedy recovery enables BPH patients with chronic illnesses, less prone to new complications.
Minimally invasive therapies do not cause new, sustained erectile or ejaculatory dysfunction, which means BPH treatments do not add more problems to chronic patients’ post-treatment.
It will reduce delays in BPH treatments due to chronic disease complications.
These factors clearly define why minimally invasive therapies like Prostatic Urethral Lift have become a ray of hope for men with BPH and chronic diseases. Despite being novel treatment methods in the field of BPH treatments, they have proven robust data for more than five years.
Gradually, they are gaining preference over other treatment options due to speedy recovery and fewer side effects. While many patients in India have already undergone minimally invasive treatment and are pursuing their lives healthily and happily post-BPH treatment, others are in the queue for ditching traditional BPH treatment methods and choosing minimally invasive therapies.